A Multicenter Study to Compare the Efficacy of an Extended-cycle Oral Contraceptive, Seasonique [ethinylestradiol/levonorgestrel 0.03/0.15mg + ethinylestradiol 0.01mg] Which Utilizes Ethinyl Estradiol During the Usual Hormone-free Interval to Placebo for the Treatment of Cyclic Pelvic Pain in Adolescents.

Trial Profile

A Multicenter Study to Compare the Efficacy of an Extended-cycle Oral Contraceptive, Seasonique [ethinylestradiol/levonorgestrel 0.03/0.15mg + ethinylestradiol 0.01mg] Which Utilizes Ethinyl Estradiol During the Usual Hormone-free Interval to Placebo for the Treatment of Cyclic Pelvic Pain in Adolescents.

Completed
Phase of Trial: Phase II

Latest Information Update: 24 Sep 2016

At a glance

  • Drugs Ethinylestradiol/levonorgestrel (Primary) ; Ethinylestradiol
  • Indications Dysmenorrhoea
  • Focus Therapeutic Use
  • Sponsors Duramed Pharmaceuticals Inc
  • Most Recent Events

    • 24 May 2012 Trial phase changed from III to II, actual patient number 95 and company (Teva Pharmaceutical Industries) added as reported by ClinicalTrials.gov.
    • 07 Jun 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 07 Jun 2011 Actual end date (Oct 2008) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top